SURVANTA (beractant) Survanta For the treatment and prevention
Health Care Professionals Parent Information Prescribing Information
 
Home
Download the 2007 NeoFax Manual.
Click Here

Watch the Survanta Dosing Video
Click Here

Download the National Respiratory Disease Newsletter
Click Here

Health Care ProfessionalsOver 800,000 infants treated since 1991*
Clinical Studies
Additional Studies
Follow-Up Studies
Prenatal Corticosteroids and Postnatal Surfactant
Epidemiologic Research
Surfactant Therapy Overview

Clinical Studies

Zola EM, Overbach AM, Gunkel JH, et al: Treatment investigational new drug experience with Survanta (beractant).
Pediatrics 1993;91:546-551.

Hoekstra RE, Jackson JC, Myers TF, et al: Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome.
Pediatrics 1991;88:10-18.

Liechty EA, Donovan E, Purohit D, et al: Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome.
Pediatrics 1991;88:19-28.

* IMS DDD Lung Surfactant Market Purchases July 1991 through June 2008. On file, Abbott Nutrition Marketing Research.